Ask AI
ProCE Banner Activity

Metabolic Modulation in HIV: Utilizing GLP-1 Receptor Agonists for Weight Management 

Clinical Thought

Body habitus changes in people living with HIV can negatively affect mental health, quality of life, and even adherence to HIV treatment. Read on to learn how GLP-1 receptor agonists may help and who are the strongest candidates for these agents.

Released: March 05, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Theratechnologies.

Theratechnologies

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who provide care for people living with HIV.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify individuals who are appropriate candidates for pharmacologic interventions that may ameliorate obesity or visceral fat accumulation in people living with HIV

Disclosure

Primary Author

Grace A. McComsey, MD, FIDSA: consultant/advisor/speaker: Gilead, GSK, Merck.